Aspirin Research Today is a free monthly online journal that collates and summarizes the latest research about Aspirin, including details on acetylsalicylic acid, baby aspirin, side effects, overdose, allergy. | ||||||||
|
Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen.Urios P, Grigorova-Borsos AM, Sternberg M
Aspirin showed an inhibitory effect on the formation of pentosidine, a cross-linking advanced glycation endproduct, in collagen incubated with glucose in vitro. IC(50) was evaluated at 10mmol/l. Aspirin might act by metallic ion chelating (as did EDTA and DTPA) and by oxygen radical scavenging. Since aspirin was reported to inhibit retinopathy in diabetic dogs, it could act partly by inhibiting advanced glycation endproduct accumulation in long-lived proteins like collagens. Published 7 May 2007 in Diabetes Res Clin Pract, 77(2): 337-40.
© 2004-2008 Aspirin Research Today. All Rights Reserved. |
| ||||||